These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 324678)

  • 1. C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.
    Tappeiner G; Heine KG; Kahl JC; Jordon RE
    Clin Exp Immunol; 1977 Apr; 28(1):40-8. PubMed ID: 324678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study on 70 human embryos concerning the epidermal binding of pemphigus and pemphigoid antibodies.
    Varelzidis A; Tosca A; Coumantakis E; Nicolis G; Hatzis J; Papavasiliou S; Stratigos J
    Acta Derm Venereol; 1980; 60(2):129-33. PubMed ID: 6155018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
    Jordon RE; Struve MF; Bushkell LL
    Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
    Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
    Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
    Zubler RH; Lange G; Lambert PH; Miescher PA
    J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes in pemphigus and bullous pemphigoid.
    Ahmed AR; Moy RL; Chia D; Barnett EV
    Dermatologica; 1983; 166(4):175-80. PubMed ID: 6343146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies.
    Jordon RE; McDuffie FC
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):594-8. PubMed ID: 768993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.
    Rossen RD; Zubler RH; Day NK; Reisberg MA; Morgan AC; Gutterman JU; Hersh EM
    J Lab Clin Med; 1978 Feb; 91(2):191-204. PubMed ID: 413872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in pemphigus and bullous pemphigoid.
    Jordon RE
    J Invest Dermatol; 1976 Sep; 67(3):366-71. PubMed ID: 787432
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ; Patel H; Diaz LA
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features.
    Kauffmann RH; Herrmann WA; Meijer CJ; Daha MR; Vanes LA
    Clin Exp Immunol; 1980 Sep; 41(3):459-70. PubMed ID: 7438561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
    Shepherd PS
    Clin Exp Immunol; 1979 May; 36(2):250-5. PubMed ID: 477028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting.
    Kiss M; Husz S; Molnár K; Dobozy A
    Acta Microbiol Immunol Hung; 1996; 43(2-3):115-23. PubMed ID: 8876727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies].
    Sobel A; Gabay Y; Lagrue G
    Nouv Presse Med; 1976 Jun; 5(23):1465-9. PubMed ID: 132639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of bullous pemphigoid antibodies to basal cells.
    Nishikawa T; Kurihara S; Harada T; Hatano H
    J Invest Dermatol; 1980 Jun; 74(6):389-91. PubMed ID: 6991608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pemphigus and pemphigoid].
    Stewart WM
    Dermatologica; 1980; 160(4):217-35. PubMed ID: 6987108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of the biotin-avidin system to the study of autoimmune bullous diseases: immunofluorescence method using biotinylated-pemphigus and -pemphigoid antibodies and fluoresceinated avidin].
    Muramatsu T; Sakamoto K; Ikeda S
    Nihon Hifuka Gakkai Zasshi; 1988 Sep; 98(10):977-80. PubMed ID: 3065537
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding of bullous pemphigoid and pemphigus vulgaris sera to SCaBER cell line in an ELISA.
    Cook AL; Mallett RB; Hanahoe TH; Pye RJ
    Br J Dermatol; 1989 Jan; 120(1):59-69. PubMed ID: 2700665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.